Participation of endogenous endothelins in delayed eosinophil and neutrophil recruitment in mouse pleurisy

Inflammation Research

Volumn 49, Issue 4, 2000, Pages 170-176

  Sampaio, A L F ^a   Rae, G A ^b   Henriques, M G M O ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Allergy; Endothelin; Eosinophil; LPS; Neutrophil

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BOSENTAN; CARRAGEENAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; OVALBUMIN; ZYMOSAN;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; MALE; MONONUCLEAR CELL; MOUSE; NEUTROPHIL; NONHUMAN; PLEURISY;

ANIMALS; ENDOTHELINS; EOSINOPHILS; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MICE; NEUTROPHIL INFILTRATION; NEUTROPHILS; OLIGOPEPTIDES; OVALBUMIN; PEPTIDES, CYCLIC; PIPERIDINES; PLEURISY; PROTEINS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 0034101903     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050577     Document Type: Article

References (42)

1. [1] Webb DJ. Endothelin: from molecule to man. Br J Clin Pharmacol 1998; 44: 9-20.
2. [2] Masaki T, Vane JR and Vanhoutte PM. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev 1994; 46: 137-42.
3. [3] Clozel M, Breu V, Gray GA, Kalina B, Loffler BM, Burri K, et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994; 270: 228-35.
4. 2. Br J Pharmacol 1994; 112: 963-71.
5. B receptors. Br J Pharmacol 1995; 115: 227-36.
6. [6] Ishida K, Takeshige K and Minakami S. Endothelin-1 enhances Superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenyl-alanine. Biochem Biophys Res Commun 1990; 173: 496-500.
7. [7] McCarron RM, Wang L, Stanimirovic DB, Spatz M. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 1993; 156: 31-4.
8. [8] Helset E, Sildnes T, Konopski ZS. Endothelin-1 stimulates monocytes in vitro to release chemotactic activity identified as interleukin-8 and monocyte chemotatic protein-1. Mediators Inflamm 1994; 3: 155-60.
9. 4 from mouse bone marrow-derived mast cells. Eur J Pharmacol 1994; 257: 235-42
10. [10] Filep JG, Telemaque S, Battistini B, Sirois P, D'Orléans-Juste P. Increased plasma levels of endothelin during anaphylactic shock in the guinea-pig. Eur J Pharmacol 1993; 239: 231-6.
11. [11] Sugiura M, Inagami T, Kon V Endotoxin stimulates endothelin release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989; 161: 1220-7.
12. [12] Vemulapalli S, Chim PJ, Rivelli M, Foster CJ, Sybertz EJ. Modulation of circulating endothelin levels in hypotension and endotoxemia in rats. J Cardiovasc Pharmacol 1991; 18: 895-903.
13. [13] Julkunen H, Saijenmaa O, Gronhagen Riska C, Teppo AM, Fyhrquist F. Raised plasma concentrations of endothelin-1 in systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 526-7.
14. [14] Matsuda J, Tsukamoto M, Gohchi K, Saitoh N, Miyajima Y, Kazama M. Effect of total body cold exposure on plasma concentration of Von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon. Acta Haematol 1992; 88: 189-93.
15. [15] Takakuwa T, Endo S, Nakae H, Kikichi M, Suzuki T, Inada K, et al. Plasma levels of TNF-alpha endothelin-1 and thrombomodulin in patients with sepsis. Res Commun Chem Pathol Pharmacol 1994; 84: 261-69.
16. [16] Nomura A, Uchida Y, Kaneyana M, Saotome M, Oki K, Hasegawa S. Endothelin and bronchial asthma. Lancet 1989; 2: 747-8.
17. [17] Mattoli S, Soloperto M, Marini M, Fasoli. Levels of endothelin-1 in the brochoalveolar lavage fluid of patients with symptomatic asthma and reversible airflow obstruction. J Allergy Clin Immunol 1991; 88: 376-384.
18. [18] Nahir AM, Hoffman A, Lorber M, Keiser HR. Presence of immunoreactive endothelin in synovial fluid: analysis of 22 cases. J Rheumatol 1991; 18:678-80.
19. [19] Miyasaka N, Hirata Y, Ando K, Sato K, Morita H, Schichiri M, et al. Increased production of endothelin-1 patients with inflammatory arthritides. Arthritis Rheum 1992; 35: 397-400.
20. A receptor antagonists inhibit allergic inflammation in the mouse. J Cardiovasc Pharmacol 1995; 26 (suppl. 3): S416-8.
21. [21] Finsnes F, Skjønsberg OH, Tønnessen T, Næss O, Lyberg T, Christensen G. Endothelin production and effects of endothelin antagonism during experimental airway inflammation. Am J Respir Crit Care Med 1997; 155: 1404-12.
22. [22] Fujitani Y, Trifilieff A, Tsuyuki S, Coyle AJ, Bertrand C. Endothelin receptor antagonists inhibit antigen-induced lung inflammation in mice. Am J Resp Crit Care Med 1997; 155: 1890-94.
23. [23] Sampaio ALF, Rae GA, Henriques MGMO. Role of endothelins on lymphocyte accumulation in allergic pleurisy. J Leukocyte Biol 2000; 67: 189-95.
24. [24] Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-10.
25. [25] Henriques MGMO, Rae GA, Cordeiro RSB and Williams TJ. Endothelin-1 inhibits PAF-induced paw edema and pleurisy in the mouse. Br J Pharmacol 1992; 106: 579-82.
26. [26] Elferink JG, de Koster BM. Endothelin-1-induced activation of neutrophil migration. Biochem Pharmacol 1994; 48: 865-71.
27. [27] Elferink JG, de Koster BM. Modulation of human neutrophil chemotaxis by endothelin-B receptor agonist sarafotoxin S6c. Chem Biol Interac 1996; 101: 165-74.
28. [28] Helset E, Ytrehus K, Tevita T, Kjaeve J, Jorgensen L. Endothelin-1 causes accumulation of leukocytes in pulmonary circulation. Circ Shock 1994; 44: 201-9.
29. [29] Hofman FM, Chen P, Jeyaseelan R, Incardona F, Fisher M, Zidovetzki R. Endothelin-1 induces production of the neutrophil chemotactic factor interleukin-8 by human brain endothelial cells. Blood 1998; 92: 3064-72.
30. [30] Helset E, Sildnes T, Konopski ZS. Endothelin-1 stimulates monocytes in vitro to release chemotactic activity identified as interleukin-8 and monocyte chemotatic protein-1. Mediators Inflamm 1994; 3: 155-60.
31. [31] Kelly EA, Rodriguez RR, Busse WW, Jarjour NN. The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am J Respir Crit Care Med 1997; 156: 1421-8.
32. [32] Palframan RT, Collins PD, Williams TJ, Rankin SM. Eotaxin induces rapid release of eosinophils and their progenitors from bone marrow. Blood 1998; 91: 2240-8.
33. + T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993; 92: 313-24.
34. [34] Hamelmann E, Oshiba A, Loader J, Larsen GL, Gleich G, Lee J, Gelfand EW. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Crit Care Med 1997; 155: 819-25.
35. [35] Garlisi CG, Falcone A, Hey JA, Paster TM, Fernandez X, Rizzo CA, et al. Airway eosinophils, T cells, Th2-type cytokine mRNA, and hyperreactivity in response to aerosol challenge of allergic mice with previously established pulmonary inflammation. Am J Respir Cell Mol Biol 1997; 17: 642-5.
36. [36] Bozza PT, Castro-Faria-Neto HC, Penido C, Laranjeira AP, Silva PMR, Martins MA, et al. IL-5 accounts for the mouse pleural eosinophil accumulation triggered by antigen but not by LPS. Immunopharmacology 1994; 27: 131-36.
37. [37] Penido C, Castro-Faria-Neto HC, Larangeira AP, Rosas EC, Ribeiro-dos-Santos R, Bozza PT, et al. The role of gamma delta T lymphocytes in lipopolysaccharide-induced eosinophil accumulation into the mouse pleural cavity. J Immunol 1997; 159 (2): 853-60.
38. [38] Foster CA. VCAM-1/4-integrin adhesion pathway: Therapeutic target for allergic inflammatory disorders. J Allergy Clin Immunol 1996; 98: S270-7.
39. [39] IshizukaT, Takamizawa-Matsumoto M, Suzuki K, Kurita A. Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor alpha-stimulated vascular endothelial cells. Eur J Pharmacol 1999; 369: 237-45.
40. A receptors and platelet-activating factor. Br J Pharmacol 1999; 127: 969-79.
41. [41] Rae GA, Henriques MGMO. Endothelins in inflammation. In: Proinflammatory and Antiinflammatory Peptides. S.I. Said editor. Lung Biology in Health and Disease Series. Marcel Dekker, New York, 1997; 112: 163-202.
42. B receptor activation. Br J Pharmacol 2000; 29: 961-68.